Ceres Inc
TSE:3696
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Ceres Inc
Cash Equivalents
Ceres Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ceres Inc
TSE:3696
|
Cash Equivalents
ÂĄ8.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Hakuhodo DY Holdings Inc
TSE:2433
|
Cash Equivalents
ÂĄ184.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CyberAgent Inc
TSE:4751
|
Cash Equivalents
ÂĄ204.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
24%
|
|
Dentsu Group Inc
TSE:4324
|
Cash Equivalents
ÂĄ275.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Septeni Holdings Co Ltd
TSE:4293
|
Cash Equivalents
ÂĄ25.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Vector Inc
TSE:6058
|
Cash Equivalents
ÂĄ15.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
21%
|
CAGR 10-Years
29%
|
See Also
What is Ceres Inc's Cash Equivalents?
Cash Equivalents
8.8B
JPY
Based on the financial report for Mar 31, 2024, Ceres Inc's Cash Equivalents amounts to 8.8B JPY.
What is Ceres Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
15%
Over the last year, the Cash Equivalents growth was 54%. The average annual Cash Equivalents growth rates for Ceres Inc have been 16% over the past three years , 15% over the past five years .